Cargando…
Effective chemoimmunotherapy by co-delivery of doxorubicin and immune adjuvants in biodegradable nanoparticles
Chemoimmunotherapy is an emerging combinatorial modality for the treatment of cancers resistant to common first-line therapies, such as chemotherapy and checkpoint blockade immunotherapy. We used biodegradable nanoparticles as delivery vehicles for local, slow and sustained release of doxorubicin, t...
Autores principales: | Da Silva, Candido G., Camps, Marcel G.M., Li, Tracy M.W.Y., Zerrillo, Luana, Löwik, Clemens W., Ossendorp, Ferry, Cruz, Luis J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771237/ https://www.ncbi.nlm.nih.gov/pubmed/31588231 http://dx.doi.org/10.7150/thno.34429 |
Ejemplares similares
-
Liposome-Based Drug Delivery Systems in Cancer Immunotherapy
por: Gu, Zili, et al.
Publicado: (2020) -
A dual-responsive doxorubicin–indoximod conjugate for programmed chemoimmunotherapy
por: Yang, Zhaoxuan, et al.
Publicado: (2022) -
Upconversion nanoparticle platform for efficient dendritic cell antigen delivery and simultaneous tracking
por: Yu, Zhenfeng, et al.
Publicado: (2022) -
Biomimetic doxorubicin/ginsenoside co-loading nanosystem for chemoimmunotherapy of acute myeloid leukemia
por: Chen, Mo, et al.
Publicado: (2022) -
Targeted delivery of liposomal chemoimmunotherapy for cancer treatment
por: Liu, Yusheng, et al.
Publicado: (2022)